FDA Inspection 1221247 — Contract Pharmaceuticals Limited Canada

Contract Pharmaceuticals Limited Canada — FEI 3011158222

The FDA completed an inspection of Contract Pharmaceuticals Limited Canada on September 13, 2023 in Mississauga. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 13, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Mississauga (Canada)